Objective: The aim of this paper is to critically review the literature on major mental illness and problematic substance use in order to provide clinicians and policymakers with evidence to support proposed directions for management of the above.
Method: The available literature was accessed using computerised databases and manual searching.
Results: The predominantly North American-based literature is largely descriptive. Those studies which attempt empirical evaluation are limited by methodological weaknesses which include small sample sizes, short follow-up periods, inadequate measurement of substance use, lack of experimental design, and treatment drift over time. However, there is consensus among most studies regarding prevalence rates and treatment.
Conclusions: Problematic substance use is the most common comorbid condition among people with a major mental illness and is associated with poorer patient outcomes. There is evidence to suggest that the integration of mental health and drug and alcohol services will result in improved detection, assessment and management of comorbidity. Integration refers to the provision of comprehensive services by a single service with staff who are competent in both mental health and drug and alcohol skills. A tolerant, non-confrontational approach to substance use is most appropriate for people with a major mental illness. Treatment programs need to recognise the longitudinal nature of substance abuse and dependence. More research needs to be conducted in this field in order to establish guidelines for effective management.
RegierDAFarmerMERaeDSComorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association1990; 264:2511–2518.
2.
HallW.What have population surveys revealed about substance use disorders and their co-morbidity with other mental disorders?Drug and Alcohol Review1996; 15:157–170.
3.
WellsJEBushnellJAHornblowARJoycePROakley-BrowneMAChristchurch Psychiatric Epidemiology Study, Part I. Methodology and lifetime prevalence for specific-psychiatric disorders. Australian and New Zealand Journal of Psychiatry1989; 23:315–326.
4.
Oakley-BrowneMAJoycePRWellsJEBushnellJAHornblowARChristchurch Psychiatric Epidemiology Study, Part 11. Six month and other period prevalences of specific psychiatric disorders. Australian and New Zealand Journal of Psychiatry1989; 23:327–340.
5.
BlandRCNewmanSCOrnH.Alcohol abuse and dependence in Edmonton, Canada. In: HelzerJECaninoGJ, eds. Alcoholism in North America, Europe and Asia. New York: Oxford University Press, 1992:97–112.
6.
JenkinsRLewisGBebbingtonPThe National Psychiatric Morbidity Surveys of Great Britain —initial findings from the Household Survey. Psychological Medicine1997; 27:775–789.
7.
WellsJWBushnellJAJoycePRHornblowAROakley-BrowneMAAlcohol abuse and dependence in New Zealand. In: HelzerJECaninoGJ, eds. Alcoholism in North America. Europe and Asia. New York: Oxford University Press, 1992:199–214.
8.
du GalbaudFort GNewmanSCBlandRCPsychiatric comorbidity and treatment seeking. Journal of Nervous and Mental Disease1993; 181:467–474.
9.
BlandRCOrnHNewmanSCLifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatrica Scandinavica1988; 77(Suppl. 338):24–32.
10.
KesslerRCMcGonagleKAZhaoSLifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry1994; 51:8–19.
11.
RegierDANarrowWERaeDSManderscheidRWLockeBZGoodwinMDThe de facto US mental and addictive disorders service system: epidemiological catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry1993; 50:85–94.
12.
KesslerRCEpidemiology of psychiatric comorbidity. In: TsuangMTohenMZahnerG, eds. Textbook in psychiatric-epidemiology. New York: Wiley, 1995:179–197.
13.
MueserKTBennettMKushnerMGEpidemiology of substance use disorders among persons with chronic mental illnesses. In: LehmanAFDixonLB, eds. Double jeopardy: chronic mental illness and substance use disorders. Chur, Switzerland: Harwood Academic, 1995:9–25.
14.
LehmanAFMyersPCCortyEThompsonJWPrevalence and patterns of ‘Dual Diagnosis’ among psychiatric inpatients. Comprehensive Psychiatry1994; 35:106–112.
15.
TestAMKnoedlerWHAllnessDJBurkeSSCharacteristics of young adults with schizophrenic disorders treated in the community. Hospital and Community Psychiatry1985; 36:853–858.
16.
SaferDJSubstance abuse by young adult chronic patients. Hospital and Community Psychiatry1985; 38:511–514.
17.
DrakeREWallachMASubstance use among the chronically mentally ill. Hospital and Community Psychiatry1989; 40:1041–1046.
18.
DrakeREOsherFCWallachMAAlcohol use and abuse in schizophrenia. Journal of Nervous and Mental Disease1989; 177:408–414.
19.
BartelsSJTeagueGBDrakeREClarkREBushPWNoordsyDLSubstance abuse in schizophrenia: service utilization and costs. Journal of Nervous and Mental Disease1993; 181:4227–4232.
20.
OsherFCDrakeRENoordsyDLCorrelates and outcomes of alcohol disorder among rural outpatients with schizophrenia. Journal of Clinical Psychiatry1994; 55:109–113.
21.
BattelsSEDrakeREWallachMALong-term course of substance use disorders among patients with severe mental illness. Psychiatric Services1995; 46:248–251.
22.
Kozaric-KovacicDFolnegovicVFolnegovicZMarusicA.Influence of alcoholism on the prognosis of schizophrenic patients. Journal of Studies on Alcohol1995; 56:622–627.
23.
MenezesPRJohnsonSThornicroftGDrug and alcohol problems among individuals with severe mental illness in South London. British Journal of Psychiatry1996; 168:612–619.
24.
SwoffordCDKasckowJWSceller-GilkeyGInderbitzenLBSubstance use: a powerful predictor of relapse in schizophrenia. Schizophrenia Research1996; 20:145–151.
25.
OwenRRFischerEPBoothBMCuffelBJMedication non-compliance and substance abuse among patients with schizophrenia. Psychiatric Services1996; 47:853–858.
26.
KovasznayBFleischerJTanenberg-KarantMJandorfLMillerADBrometE.Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophrenia Bulletin1997; 23:195–201.
27.
RichardMLLiskowBIPerryPJRecent psychostimulant use in hospitalised schizophrenics. Journal of Clinical Psychiatry1985; 46:79–83.
28.
DixonLHaasGWeidenPJSweeneyJFrancesAJDrug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry1991; 148:224–230.
29.
CroweDBRosseRBSheridanMJDeutschSISubstance use diagnosis and discharge patterns among psychiatric inpatients. Hospital and Community Psychiatry1991; 42:403–405.
30.
FowlerILCarrVJCarterNTLewinTJPatterns of current and lifetime substance use in schizophrenia. Schizophrenia Bulletin (in press).
31.
CuffelBJChaseMSRemission and relapse of substance use disorders in schizophrenia: results from a one-year prospective study. Journal of Nervous and Mental Disease1994; 182:342–348.
32.
CuffelBJComorbid substance use disorder: prevalence, patterns of use, and course. New Directions for Mental Health Services1996; 70:93–105.
33.
BaigentMHolmeGHafnerRJSelf-reports of the interaction between substance abuse and schizophrenia. Australian and New Zealand Journal of Psychiatry1995; 29:69–74.
34.
BrunetteMFMueserKTXieHDrakeRERelationships between symptoms of schizophrenia and substance abuse. Journal of Nervous and Mental Disease1997; 185:13–20.
35.
KnudsenPVilmarT.Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatrica Scandinavica1984; 69:162–174.
36.
ArndtSTyrrellGFlaumMAndreasenNCComorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychological Medicine1992; 22:379–388.
37.
SmithJHuckerS.Schizophrenia and substance abuse. British Journal of Psychiatry1994; 165:13–21.
38.
DrakeRERosenbergSDMueserKTAssessing substance use disorder in persons with severe mental illness. New Directions for Mental Health Services1996; 70:3–17.
39.
MillingRNFaulknerLRCraigJMProblems in the recognition and treatment of patients with dual diagnosis. Journal of Substance Abuse Treatment1994; 11:267–271.
40.
AnanthJVandewaterSKamalSBrokskyAGamalRMillerM.Missed diagnosis of substance abuse in psychiatric patients. Hospital and Community Psychiatry1989; 4:297–299.
41.
DrakeREOsherFCNoordsyDLHurlbutSCTeagueGBBeaudettMSDiagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin1990; 16:57–67.
42.
CareyKBCoccoKMSimonsJSConcurrent validity of clinicians’ ratings of substance abuse among psychiatric outpatients. Psychiatric Services1996; 47:842–847.
43.
McHugoGJPaskusTSDrakeREDetection of alcoholism in schizophrenia using the MAST. Alcoholism: Clinical and Experimental Research1993; 17:187–191.
44.
ApplebyLDysonVLuchinsDJCohenLSThe impact of substance use screening on a public psychiatric inpatient population. Psychiatric Services1997; 48:1311–1316.
45.
ProchaskaJODiClementeCCNorcrossJCIn search of how people change: applications to addictive behaviours. American Psychologist1992; 47:1102–1114.
46.
ZiedonisDMTrudeauK.Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophrenia Bulletin1997; 23:229–238.
47.
OsherFCKofoedLLTreatment of patients with psychiatric and psychoactive substance abuse disorders. Hospital and Community Psychiatry1989; 40:1025–1030.
48.
McHugoGJDrakeREBurtonHLAckersonTHA scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease1995; 183:762–767.
49.
DrakeREMueserKTClarkREWallachMAThe course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry1996; 66:42–51.
50.
RidgelyMSGoldmanHHWillenbringM.Barriers to the care of persons with dual diagnoses: organizational and financing issues. Schizophrenia Bulletin1990; 16:123–132.
51.
MinkhoffK.An integrated treatment model for dual diagnosis of psychosis and addiction. Hospital and Community Psychiatry1989; 40:1031–1036.
52.
DrakeRETeagueGBWarrenSRDual diagnosis: the New Hampshire program. Addiction and Recovery1990; 10:35–39.
53.
DaleyDCSalloumIJones-BarlockA.Integrating a dual-disorder program in an acute-care psychiatric hospital. Psychosocial Rehabilitation Journal1990; 13:45–56.
54.
DrakeREBartelsJBTeagueGBNoordsyDLClarkRETreatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease1993; 181:606–611.
55.
GalanterMEgelkoSEdwardsHVergarayM.A treatment system for combined psychiatric and addictive illness. Addiction1994; 89:1227–1234.
56.
ConnerKRSilversteinSMMcCullockMelnyk KAMaxeyJTThe development of a partial hospitalization program for mentally ill chemically abusing (MICA) patients. Journal of Substance Abuse Treatment1995; 12:311–318.
57.
CareyKBSubstance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational harm reduction approach. Community Mental Health Journal1996; 32:291–306.
58.
BradizzaCMStasiewiczPRIntegrating substance abuse treatment for the seriously mentally ill into inpatient psychiatric treatment. Journal of Substance Abuse Treatment1997; 14:103–111.
59.
Mercer-McFaddenCDrakeREBrownNBFoxRSThe community support program demonstrations of services for young adults with severe mental illness and substance use disorders, 1987–91. Psychiatric Rehabilitation Journal1997; 20:13–24.
60.
MueserKTDrakeREMilesKMThe course and treatment of substance use disorder in persons with severe mental illness. In: OnkenLSBlaineJDGenserSHortonAM, eds. Treatment of drug-dependent individuals with comorbid mental disorders. National Institue of Drug Abuse (NIDA) Research Monograph 172. Rockville, MD: United States Department of Health and Human Services, 1997, 172:86–109.
61.
KofoedLKaniaJWalshTAtkinsonRMOutpatient treatment of patients with substance abuse and coexisting psychiatric disorders. American Journal of Psychiatry1986; 143:867–872.
62.
BondGRMcDonelECMillerLDPensecM.Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991; 15:31–43.
63.
SwindleRWPhibbsCSParadideMJRecineBPMoosRHInpatient treatment for substance abuse patients with psychiatric disorders: a national study of determinants of readmission. Journal of Substance Abuse1995; 7:79–97.
64.
DrakeREMcHugoGJNoordsyDLTreatment of alcoholism among schizophrenic outpatients: 4-year outcomes. American Journal of Psychiatry1993; 150:328–329.
65.
BartelsSJDrakeREA pilot study of residential treatment for dual diagnoses. Journal of Nervous and Mental Disease1996; 184:379–381.
66.
DrakeREYovetichNABeboutRRHarrisMMcHugoGJIntegrated treatment for dually diagnosed homeless adults. Journal of Nervous and Mental Disease1997; 185:298–305.
67.
JerrelJMRidgelyS.Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995; 183:566–576.
68.
JerrelJMRidgelyMSEvaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment. Psychiatric Services1995; 46:233–238.
69.
CrumpMTMillingRNThe efficacy of substance abuse education among dual-diagnosis patients. Journal of Substance Abuse Treatment1996; 13:141–144.